Morin mitigates ifosfamide induced nephrotoxicity by regulation of NF-kappaB/p53 and Bcl-2 expression
- 17 January 2022
- journal article
- research article
- Published by Taylor & Francis in Biotechnic & Histochemistry
- Vol. 97 (6) , 423-432
Abstract
Ifosfamide (IFO) is used for treating childhood solid tumors, but its use is limited by its adverse effects on kidneys. Morin may be used to prevent nephrotoxic and other side effects. We investigated the underlying mechanisms of the protective effects of morin on IFO induced nephrotoxicity. We used 35 male rats divided into five groups of seven: control group, morin group, IFO group, 100 mg/kg morin + IFO group and 200 mg/kg morin + IFO group. We measured kidney tissue oxidant, antioxidant and inflammatory parameters using ELISA, and apoptosis was evaluated using immunohistochemistry and real time PCR. Serum urea, creatinine and kidney injury molecule-1 (KIM-1) levels were increased by IFO treatment; elevated levels were decreased significantly by treatment with both 100 and 200 mg/kg morin. Morin treatment also decreased oxidative stress and lipid oxidation in IFO treated rats. The ameliorative effect of morin on inflammatory response was due to reduced levels of NF-κB and TNF-α. Morin also reduced NF-κB/p53 levels by increasing Bcl-2 expression in IFO treated kidneys. Morin may prevent IFO induced nephrotoxicity via the NF-κB/p53 and Bcl-2 signaling pathways.Keywords
This publication has 63 references indexed in Scilit:
- Downregulation of Oxidative and Nitrosative Apoptotic Signaling by L-Carnitine in Ifosfamide-Induced Fanconi Syndrome Rat ModelOxidative Medicine and Cellular Longevity, 2012
- Protective Role of Morin, a Flavonoid, against High Glucose Induced Oxidative Stress Mediated Apoptosis in Primary Rat HepatocytesPLOS ONE, 2012
- siRNA Targeted to p53 Attenuates Ischemic and Cisplatin-Induced Acute Kidney InjuryJournal of the American Society of Nephrology, 2009
- N‐Acetylcysteine prevents ifosfamide‐induced nephrotoxicity in ratsBritish Journal of Pharmacology, 2008
- Resveratrol improves ifosfamide-induced Fanconi syndrome in ratsToxicology and Applied Pharmacology, 2007
- Chronic Health Conditions in Adult Survivors of Childhood CancerNew England Journal of Medicine, 2006
- Stress-induced p53 runs a transcription-independent death programBiochemical and Biophysical Research Communications, 2005
- Melatonin attenuates ifosfamide‐induced Fanconi syndrome in ratsJournal of Pineal Research, 2004
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Ifosfamide/MesnaDrugs, 1991